Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Senexis secures new funding to develop innovative compounds for AD

Jan. 22, 2008

Recent Sia Peptides patent discloses new stress-relieving agents

Jan. 21, 2008

FDA places clinical hold on YM BioSciences' phase II AP5 study of AeroLEF for pain

Jan. 21, 2008

Targeting specific GABA-A receptor subunits shows potential in treating chronic pain

Jan. 21, 2008

Hydrogen peroxide scavenging prolongs life span in experimental Friedreich's ataxia

Jan. 21, 2008

XenoPort and GSK report top-line results for XP-13512 in the treatment of RLS

Jan. 18, 2008

EPIX reports revised results from its phase IIa clinical trial of PRX-03140 in AD

Jan. 18, 2008

Schering-Plough files NDA for sugammadex in Japan

Jan. 18, 2008

Novel treatment for spinal cord disorders reported in recent Sia Peptides patent

Jan. 18, 2008

Cerimon initiates phase II/III trials of once-daily diclofenac sodium patch for pain

Jan. 18, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...